Revenue + Forward P/E
Medpace Holdings, Inc. (MEDP) quarterly revenue and forward P/EForward P/E: 32.5x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$16.38B
Enterprise value
$14.70B
P/E ratio (TTM)
30.37x
P/S ratio (TTM)
5.42x
P/B ratio
34.46x
EV/Sales
5.28x
EV/EBITDA
23.98x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$2.53B
Gross profit (TTM)
$760.62M
Operating income (TTM)
$534.94M
EBITDA (TTM)
$570.50M
Net income (TTM)
$451.12M
Free cash flow (TTM)
$681.87M
Margins & returns
Gross margin
28.76%
Operating margin
20.97%
Profit margin
17.67%
Return on equity
110.15%
Return on assets
23.89%
Per-share metrics
EPS (TTM)
$17.36
Dividend yield
0.00%
Beta
1.15
Capital structure
Cash & equivalents
$497.05M
Total debt
$250.50M
Net debt
$-246.55M
Shares outstanding
27.91M
Financial health
Current ratio
0.74
Debt / equity
0.55
Debt / assets
0.13
Interest coverage
-
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $630.35B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.35B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.12B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.97B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $16.38B | 30.37x | 5.42x | 23.98x | - |